Clinical Trial Update: Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427 [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study of ST-2427 evaluating safety, tolerability, and pharmacokinetics; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• ST-2427 (ST-2427)

Snippet

Sponsor: SiteOne Therapeutics, Inc. | Conditions: Acute, Post-operative Pain | Phase 1 | Status: TERMINATED | Results posted: 2023-08-03